▶

September, 11 2023 in Videos

23 Questions With Claire Marasco on Global Regulatory Strategies

23 Questions with Claire Marasco on Global Regulatory Strategies

By Forge Biologics

April, 3 2023 in

Forge Biologics’ cGMP Compliant and Commercially Viable Bespoke Affinity Chromatography Platform

Forge Biologics’ cGMP Compliant and Commercially Viable Bespoke Affinity Chromatography...

By Forge Biologics

February, 11 2023 in Articles, Videos

Celebrating Women at Forge for International Day of Women and Girls in Science

By Forge Biologics

December, 1 2022 in Articles

Streamline the AAV Manufacturing Process with High-Grade Starting Materials

 Streamline the AAV Manufacturing Process with High-Grade Starting Materials Authors:

By Forge Biologics

November, 16 2022 in Articles

Innovative Analytical Ultracentrifugation Techniques for the Characterization of AAV Vectors

Authors:

By Forge Biologics

November, 3 2022 in Articles, Videos

What the DMF! Spotlight on Forge's Drug Master File

Gene therapy developers' Investigational New Drug (IND) application process is arduous...

By Forge Biologics

August, 23 2022 in Articles

She Forges Turns 1: Reflecting on a Year of Celebrating, Supporting, and Elevating Women at Forge

By Forge Biologics

August, 12 2022 in Articles

Addressing the ‘Capacity Crunch’ with a Scalable Platform Process Approach

Authors: Brianna Barrett, Ph.D., Associate Director, Technical Sales, Forge Biologics ...

By Forge Biologics

▶

June, 30 2022 in Videos

Tackling CMC Challenges with ARM's Project A-Gene

By Forge Biologics

February, 28 2022 in Articles

Forge Commemorates Rare Disease Day

By Forge Biologics

Insights